Search

Your search keyword '"P. St. George-Hyslop"' showing total 629 results

Search Constraints

Start Over You searched for: Author "P. St. George-Hyslop" Remove constraint Author: "P. St. George-Hyslop"
629 results on '"P. St. George-Hyslop"'

Search Results

1. The 2022 symposium on dementia and brain aging in low‐ and middle‐income countries: Highlights on research, diagnosis, care, and impact

3. Asian Cohort for Alzheimer's Disease (ACAD) pilot study on genetic and non‐genetic risk factors for Alzheimer's disease among Asian Americans and Canadians

5. Mimicking hypomethylation of FUS requires liquid–liquid phase separation to induce synaptic dysfunctions

8. Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

9. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

10. Spatially non-uniform condensates emerge from dynamically arrested phase separation

11. Biomolecular condensate phase diagrams with a combinatorial microdroplet platform

12. Protein network analysis reveals selectively vulnerable regions and biological processes in FTD

13. Analysis of shared heritability in common disorders of the brain

14. Analysis of shared heritability in common disorders of the brain.

16. The role of contactin-associated protein-like 2 in neurodevelopmental disease and human cerebral cortex evolution

17. Transethnic genome‐wide scan identifies novel Alzheimer's disease loci

18. Reentrant liquid condensate phase of proteins is stabilized by hydrophobic and non-ionic interactions

19. Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease

20. A novel Alzheimer disease locus located near the gene encoding tau protein.

21. Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies

22. Does Soluble TREM2 Protect Against Alzheimer's Disease?

23. Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals

24. Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy Pathogenesis

25. Rarity of the Alzheimer Disease-Protective APP A673T Variant in the United States

26. Tie-Line Analysis Reveals Interactions Driving Heteromolecular Condensate Formation

27. Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease

28. Frontotemporal dementia and its subtypes: a genome-wide association study

29. Heritability and genetic variance of dementia with Lewy bodies

30. Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau

32. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

33. C-terminal calcium binding of α-synuclein modulates synaptic vesicle interaction

34. Genetically elevated high‐density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

35. Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial

36. Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies

37. TREM2 shedding by cleavage at the H157‐S158 bond is accelerated for the Alzheimer's disease‐associated H157Y variant

38. TET2 Regulates the Neuroinflammatory Response in Microglia

39. TREM2 shedding by cleavage at the H157‐S158 bond is accelerated for the Alzheimer's disease‐associated H157Y variant

40. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.

41. Excess of nicastrin in brain results in heterozygosity having no effect on endogenous APP processing and amyloid peptide levels in vivo

42. Genetic variants in the SHISA6 gene are associated with delayed cognitive impairment in two family datasets.

43. Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer’s disease mouse models with abundant Aβ in plasma

44. Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.

45. Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model

46. Additive Effects of PS1 and APP Mutations on Secretion of the 42-Residue Amyloid β-Protein

47. Presenilin Proteins Undergo Heterogeneous Endoproteolysis between Thr291and Ala299and Occur as Stable N- and C-Terminal Fragments in Normal and Alzheimer Brain Tissue

48. Correction: Is Genetically Associated with Late-Onset Alzheimer’s Disease in Japanese, Koreans and Caucasians.

49. SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians.

Catalog

Books, media, physical & digital resources